Combined hormone replacement therapy improves lipids but may increase leucocytes

Journal of Internal Medicine

Volumn 259, Issue 5, 2006, Pages 537-538

  Bergstrom H ^a   Tonstad, S ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; CHOLESTEROL; ESTRADIOL PLUS NORETHISTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS COMBINED HORMONE REPLACEMENT THERAPY; DRUG EFFECT; DRUG EFFICACY; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL;

EID: 33645967815     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01636.x     Document Type: Letter

References (3)

1. Koh KK Schenke WH Waclawiw MA Csako G Cannon RO III.. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women. Circulation 2002 105 1531 3.
2. Sbarouni E Kroupis C Kyriakides ZS Knoiavitou K Kremastinos DT. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. Eur Heart J 2000 21 975 80.
3. Manning PJ Sutherland WHF Allum AR de Jong SA Jones SD. Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with type 2 diabetes. Diabet Med 2002 19 846 52.